Lyme Disease

Latest News

Tonix In-Licenses TNX-4800 for Once-Seasonal Lyme Prophylaxis
Tonix In-Licenses TNX-4800 for Once-Seasonal Lyme Prophylaxis

September 17th 2025

TNX-4800 targets OspA to block Borrelia transmission; positive phase 1 data reported and an adaptive phase 2/3 study is planned.

Clinical Strategies for Tick Season: Lyme Prevention and Next-Gen Diagnostics
Clinical Strategies for Tick Season: Lyme Prevention and Next-Gen Diagnostics

May 9th 2025

Understanding Chronic Lyme Disease and Long COVID; MIT's New Collaboration with Movano Health
Understanding Chronic Lyme Disease and Long COVID; MIT's New Collaboration with Movano Health

June 13th 2024

New Testing Approach Identifies Lyme Disease in Immune Response
New Testing Approach Identifies Lyme Disease in Immune Response

March 16th 2022

Valneva, Pfizer Report Further Positive Data for Investigational Lyme Disease Vaccine
Valneva, Pfizer Report Further Positive Data for Investigational Lyme Disease Vaccine

February 4th 2022

Video Series
Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.